Price target
1.220.00 0.00%
The 4 analysts offering 1 year price forecasts for GNMLF have a max estimate of — and a min estimate of —.
Analyst rating
Based on 5 analysts giving stock ratings to GNMLF in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
GNMLF EPS for the last quarter is 0.02 USD despite the estimation of 0.02 USD. In the next quarter EPS is expected to reach 0.03 USD. Track more of Genomma Lab International SAB DE CV financials and stay on top of what is up with the company.
In the next quarter Genomma Lab International SAB DE CV revenue is expected to reach 255.39 M USD. Check out Genomma Lab International SAB DE CV revenue and earnings and make informed decisions.
According to analysts, GNMLF price target is 1.22 USD with a max estimate of 1.47 USD and a min estimate of 1.06 USD. Check if this forecast comes true in a year, meanwhile watch Genomma Lab International SAB DE CV stock price chart and keep track of the current situation with GNMLF news and stock market news.
We've gathered opinions of 5 analysts rating GNMLF stock in the past 3 months. After counting all points of view, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.